Qiang Tian

Dr. Qiang Tian is Professor and Director of systems biology at the International Human Phenome Institutes (IHPI) and Affiliate Professor at ISB.

He was formerly Guangci Professor and Platform CEO of the National Facility for Translational Medicine of SJTU Ruijin Hospital, Affiliate Professor at University of Washington Medical School, and CSO at P4 Medicine Institute. Dr. Tian’s translational research focuses on employing systems approach and multi-omics technologies in clinical oncology for molecular subtyping and drug-response evaluation of cancer. He also contributed to the definition and molecular phenotyping of several essential T cell subsets including Th17 and Tfh. He publishes extensively in top scientific journals and has been cited over 21,000 times.

Dr. Tian was an expert reviewer for funding agencies around the world. He collegially reaches out to global medical communities to promote Systems Medicine and P4 Healthcare which is Predictive, Preventive, Personalized, and Participatory. He is the recipient of the 2017 ANA Grace Goldsmith Award, and is President of the Seattle Chinese Biomedical Association.